Comparison of three-year outcomes after coronary stenting versus coronary artery bypass grafting in patients with multivessel coronary disease, including involvement of the left anterior descending coronary artery proximally (a subanalysis of the arterial revascularization therapies study trial)
References (18)
- et al.
Argentine Randomized Study: coronary angioplasty with stenting versus coronary bypass surgery in patients with multiple-vessel disease (ERACI II): 30-day and one-year follow-up results. ERACI II Investigators
J Am Coll Cardiol
(2001) - et al.
Three-year follow-up of the Argentine Randomized Trial of Percutaneous Transluminal Coronary Angioplasty Versus Coronary Artery Bypass Surgery in Multivessel Disease (ERACI)
J Am Coll Cardiol
(1996) - et al.
A comparison of three-year survival after coronary artery bypass graft surgery and percutaneous transluminal coronary angioplasty
J Am Coll Cardiol
(1999) - et al.
Comparison of coronary-artery bypass surgery and stenting for the treatment of multivessel disease
N Engl J Med
(2001) Coronary artery bypass surgery versus percutaneous coronary intervention with stent implantation in patients with multivessel coronary artery disease (the Stent or Surgery trial): a randomised controlled trial
Lancet
(2002)- et al.
Three year outcome after coronary stenting versus bypass surgery for the treatment of multivessel disease
Circulation
(2004) - et al.
The ARTS study (Arterial Revascularization Therapies Study)
Semin Interv Cardiol
(1999) - et al.
A reporting system on patients evaluated for coronary artery disease. Report of the Ad Hoc Committee for Grading of Coronary Artery Disease, Council on Cardiovascular Surgery, American Heart Association
Circulation
(1975) - et al.
Secular trends in Q wave and non-Q wave acute myocardial infarction. The Minnesota Heart Survey
Circulation
(1991)
There are more references available in the full text version of this article.
Cited by (10)
Percutaneous coronary invervention versus coronary artery bypass grafting: A meta-Analysis
2015, Journal of Thoracic and Cardiovascular Surgery5-Year Clinical Outcomes of the ARTS II (Arterial Revascularization Therapies Study II) of the Sirolimus-Eluting Stent in the Treatment of Patients With Multivessel De Novo Coronary Artery Lesions
2010, Journal of the American College of CardiologyCitation Excerpt :ARTS II was a multicenter, nonrandomized, open-label trial designed to compare the safety and efficacy of the SES in patients with de novo multivessel coronary artery disease, with the surgical group of ARTS I acting as a historical control (10–16).
Stenting or coronary artery bypass surgery for triple vessel disease?
2009, Annales de Cardiologie et d'AngeiologieImmediate results and clinical follow-up of patients treated with drug eluting stents implantation in routine clinical practice
2006, Annales de Cardiologie et d'AngeiologieEffects of shear forces and pressure on blood vessel function and metabolism in a perfusion bioreactor
2010, Annals of Biomedical Engineering
This study was supported by a grant from Cordis Corporation, a Johnson & Johnson, Inc., Company, New Brunswick, New Jersey.
Copyright © 2004 Excerpta Medica Inc. All rights reserved.